Savara (SVRA) Current Leases (2016 - 2018)

Savara (SVRA) posted quarterly Current Leases of $41000.0 for Q4 2018, down 84.53% year-over-year from $265000.0 in Q4 2017, and down 87.11% quarter-over-quarter from $318000.0 in Q3 2018.

Savara (SVRA) Current Leases (2016 - 2018) Analysis & Trends

Savara (SVRA) has reported Current Leases for 3 consecutive years, with $41000.0 the latest figure, recorded in Q4 2018.

  • In Q4 2018, Current Leases fell 84.53% year-over-year to $41000.0; the TTM figure through Dec 2018 stood at $41000.0 (down 84.53% YoY), while the FY2018 annual figure was $41000.0, down 84.53% from the prior year.
  • Current Leases fell to $41000.0 in Q4 2018 per SVRA's latest filing, from $318000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $719000.0 in Q2 2017 and bottomed at $21000.0 in Q1 2018.
  • Historically, Current Leases has averaged $298625.0 across 3 years, with a median of $291500.0 in 2017.
  • On a YoY basis, Current Leases climbed as much as 20.0% in 2018 and fell as far as 84.53% in 2018.
  • Savara's Current Leases stood at $442000.0 in 2016, then tumbled by 40.05% to $265000.0 in 2017, then sank by 84.53% to $41000.0 in 2018.
  • Business Quant data shows SVRA's Current Leases at $41000.0 in Q4 2018, $318000.0 in Q3 2018, and $318000.0 in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 11.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 16.75 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 21.95 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 2.24 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 45.93 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 6.27 Mn
10 Savara 1.11 Bn 1.11 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2018 41,000.00
Sep 30, 2018 318,000.00
Jun 30, 2018 318,000.00
Mar 31, 2018 21,000.00
Dec 31, 2017 265,000.00
Sep 30, 2017 265,000.00
Jun 30, 2017 719,000.00
Dec 31, 2016 442,000.00